Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer

Gastroenterology

Volumn 154, Issue 3, 2018, Pages 556-567.e18

  Gini, Andrea ^a   Zauber, Ann G ^b   Cenin, Dayna R ^a,c   Omidvari, Amir Houshang ^a   Hempstead, Sarah E ^d   Fink, Aliza K ^d   Lowenfels, Albert B ^e   Lansdorp Vogelaar, Iris ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CURTIN UNIVERSITY   (Australia)

^d CYSTIC FIBROSIS FOUNDATION   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Colonoscopy Screening; Decision Analysis; Microsimulation Modeling; Screening Ages

Indexed keywords

AGE; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; HIGH RISK PATIENT; HUMAN; LIFE EXPECTANCY; OCCULT BLOOD TEST; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; ADULT; AGED; CLINICAL DECISION MAKING; COLORECTAL TUMOR; COMPLICATION; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; EARLY CANCER DIAGNOSIS; ECONOMIC MODEL; ECONOMICS; FEMALE; HEALTH CARE COST; MALE; MARKOV CHAIN; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CLINICAL DECISION-MAKING; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MODELS, ECONOMIC; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; RISK FACTORS; STOCHASTIC PROCESSES;

EID: 85044858335     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.10.036     Document Type: Article

References (51)

1. Parkins, M.D., Parkins, V.M., Rendall, J.C., et al. Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population. Ther Adv Respir Dis 5 (2011), 105–119.
2. Farrell, P.M., The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 7 (2008), 450–453.
3. Knapp, E.A., Fink, A.K., Goss, C.H., et al. The Cystic Fibrosis Foundation Patient Registry. Design and methods of a national observational disease registry. Ann Am Thorac Soc 13 (2016), 1173–1179.
4. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2015 Annual Data Report. Bethesda, Maryland. 2016. Available at: https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report.pdf.
5. Billings, J.L., Dunitz, J.M., McAllister, S., et al. Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps. J Clin Gastroenterol 48 (2014), e85–e88.
6. Maisonneuve, P., Marshall, B.C., Knapp, E.A., et al. Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 105 (2013), 122–129.
7. Meyer, K.C., Francois, M.L., Thomas, H.K., et al. Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros 10 (2011), 366–369.
8. Niccum, D.E., Billings, J.L., Dunitz, J.M., et al. Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis. J Cyst Fibros 15 (2016), 548–553.
9. Atkin, W.S., Edwards, R., Kralj-Hans, I., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375 (2010), 1624–1633.
10. Hardcastle, J.D., Chamberlain, J.O., Robinson, M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996), 1472–1477.
11. Jorgensen, O.D., Kronborg, O., Fenger, C., A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50 (2002), 29–32.
12. Lansdorp-Vogelaar, I., van Ballegooijen, M., Boer, R., et al. A novel hypothesis on the sensitivity of the fecal occult blood test: results of a joint analysis of 3 randomized controlled trials. Cancer 115 (2009), 2410–2419.
13. Zauber, A.G., Winawer, S.J., O'Brien, M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 (2012), 687–696.
14. Mandel, J.S., Church, T.R., Ederer, F., et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91 (1999), 434–437.
15. Holme, Ø., Løberg, M., Kalager, M., et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 312 (2014), 606–615.
16. Schoen, R.E., Pinsky, P.F., Weissfeld, J.L., et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl J Med 366 (2012), 2345–2357.
17. Segnan, N., Armaroli, P., Bonelli, L., et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial - SCORE. J Natl Cancer Inst 103 (2011), 1310–1322.
18. Lieberman, D.A., Rex, D.K., Winawer, S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143 (2012), 844–857.
19. Hadjiliadis D, Khoruts A, Zauber AG, et al; on behalf of the Cystic Fibrosis Colorectal Cancer Screening Task Force. Cystic fibrosis colorectal cancer screening consensus recommendations. Gastroenterology 2018;154:736–745.
20. Vogelaar I, van Balegooijen M, Zauber AG, et al. Model profiler of the MISCAN-Colon miscosimulation model for colorectal cancer. Department of Public Health, Erasmus MC. 2004. Available at: http://cisnet.flexkb.net/mp/pub/cisnet_colorectal_sloankettering_profile.pdf.
21. van Hees, F., Habbema, J.D., Meester, R.G., et al. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med 160 (2014), 750–759.
22. Rutter, C.M., Johnson, E.A., Feuer, E.J., et al. Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst 105 (2013), 1806–1813.
23. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 9 Regs Limited Use, Nov 2002 Sub (1973–2000). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2003, based on the November 2002 submission.
24. Arminski, T.C., McLean, D.W., Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum 7 (1964), 249–261.
25. Bombi, J.A., Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer 61 (1988), 1472–1476.
26. Chapman, I., Adenomatous polypi of large intestine: incidence and distribution. Ann Surg 157 (1963), 223–226.
27. Clark, J.C., Collan, Y., Eide, T.J., et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 36 (1985), 179–186.
28. Jass, J.R., Young, P.J., Robinson, E.M., Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 33 (1992), 1508–1514.
29. Johannsen, L.G., Momsen, O., Jacobsen, N.O., Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol 24 (1989), 799–806.
30. LJ, B., Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum 4 (1961), 277–282.
31. Rickert, R.R., Auerbach, O., Garfinkel, L., et al. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 43 (1979), 1847–1857.
32. Vatn, M.H., Stalsberg, H., The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 49 (1982), 819–825.
33. Williams, A.R., Balasooriya, B.A., Day, D.W., Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 23 (1982), 835–842.
34. Knudsen, A.B., Zauber, A.G., Rutter, C.M., et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA 315 (2016), 2595–2609.
35. Belli, E.V., Landolfo, K., Keller, C., et al. Lung cancer following lung transplant: single institution 10 year experience. Lung Cancer 81 (2013), 451–454.
36. van Rijn, J.C., Reitsma, J.B., Stoker, J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101 (2006), 343–350.
37. Imperiale, T.F., Ransohoff, D.F., Itzkowitz, S.H., et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370 (2014), 1287–1297.
38. Gatto, N.M., Frucht, H., Sundararajan, V., et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 95 (2003), 230–236.
39. Schroy, P.C. 3rd, Coe, A., Chen, C.A., et al. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med 159 (2013), 13–20.
40. Warren, J.L., Klabunde, C.N., Mariotto, A.B., et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 150 (2009), 849–857, W152.
41. Leffler, D.A., Kheraj, R., Garud, S., et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Arch Intern Med 170 (2010), 1752–1757.
42. Bureau of Labor Statistics. Current Employment Statistics (National). Available at: www.bls.gov/web/empsit/ceseesummary.htm. (Accessed August 16, 2016).
43. Yabroff, K.R., Lamont, E.B., Mariotto, A., et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 100 (2008), 630–641.
44. The United States Department of Labor. Bureau of Labor Statistics. Consumer Price Index. Available at: http://www.bls.gov/cpi/tables.htm.
45. Nick, J.A., Chacon, C.S., Brayshaw, S.J., et al. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 182 (2010), 614–626.
46. Morson, B., The polyp-cancer sequence in the large bowel. Proc R Soc Med 67 (1974), 451–457.
47. Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58 (2008), 130–160.
48. Lindor, N.M., Petersen, G.M., Hadley, D.W., et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296 (2006), 1507–1517.
49. Bonadona, V., Bonaiti, B., Olschwang, S., et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305 (2011), 2304–2310.
50. MacKenzie, T., Gifford, A.H., Sabadosa, K.A., et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med 161 (2014), 233–241.
51. Kelly, T., Buxbaum, J., Gastrointestinal manifestations of cystic fibrosis. Dig Dis Sci 60 (2015), 1903–1913.